A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHL
Status:
Recruiting
Trial end date:
2026-08-23
Target enrollment:
Participant gender:
Summary
A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory
B-cell Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's Lymphoma.